Cholesterol and mevalonate : two metabolites involved in breast cancer progression and drug resistance through the ERRα pathway
(2020)
Journal Article
Brindisi, M., Fiorillo, M., Frattaruolo, L., Sotgia, F., Lisanti, M., & Cappello, A. (2020). Cholesterol and mevalonate : two metabolites involved in breast cancer progression and drug resistance through the ERRα pathway. Cells, 9(8), e1819. https://doi.org/10.3390/cells9081819
Breast cancer is the second greatest cause of cancer-related death in women. Resistance to endocrine treatments or chemotherapy is a limiting drawback. In this context, this work aims to evaluate the effects of cholesterol and mevalonate during tumor... Read More about Cholesterol and mevalonate : two metabolites involved in breast cancer progression and drug resistance through the ERRα pathway.